510(k) Market Clearance for FluChip-8G Influenza A+B AssayInDevR receives 510(k) market clearance for the first influenza diagnostic assay capable of distinguishing between seasonal and non-seasonal influenza A subtypes ... Read More
InDevR Chosen for NIH’s Innovation Zone at BIO International Convention One of select group of NIH SBIR awardees to be featured at BIO BOULDER COLORADO (4/9/19) — ... Read More
[Press Release] New VaxArray Neuraminidase Potency Test for N9InDevR launches first-in-class reagent kit for rapid quantification of N9 in “pandemic” influenza vaccines. BOULDER COLORADO (3/26/19) — InDevR ... Read More
Strictly Necessary Cookies
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.